Akt2: a role in breast cancer metastasis - PubMed (original) (raw)

Editorial

Akt2: a role in breast cancer metastasis

Noan-Minh Chau et al. Breast Cancer Res. 2004.

Abstract

Metastasis in breast cancer significantly increases morbidity and mortality. The 5-year survival rate reduces from 90% for localised disease to about 20% once metastasis has taken place. The phosphoinositide 3-kinase/Akt signalling pathway has an important role in cell motility, invasion and metastasis. However, the precise contribution of the Akt kinase family members, Akt1, Akt2 and Akt3, in mediating these processes is unclear. The possibility that they have distinct functions in tumour progression is particularly interesting.

PubMed Disclaimer

Similar articles

• Overexpression of AKT2/protein kinase Bbeta leads to up-regulation of beta1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells.
  Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY, Slamon DJ. Arboleda MJ, et al. Cancer Res. 2003 Jan 1;63(1):196-206. Cancer Res. 2003. PMID: 12517798
• Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells.
  Liu Y, Wang J, Wu M, Wan W, Sun R, Yang D, Sun X, Ma D, Ying G, Zhang N. Liu Y, et al. Mol Cancer Res. 2009 Jun;7(6):944-54. doi: 10.1158/1541-7786.MCR-08-0368. Epub 2009 Jun 16. Mol Cancer Res. 2009. PMID: 19531564
• Overexpression of Akt/AKT can modulate chemotherapy-induced apoptosis.
  Page C, Lin HJ, Jin Y, Castle VP, Nunez G, Huang M, Lin J. Page C, et al. Anticancer Res. 2000 Jan-Feb;20(1A):407-16. Anticancer Res. 2000. PMID: 10769688
• Functional and therapeutic significance of Akt deregulation in malignant melanoma.
  Robertson GP. Robertson GP. Cancer Metastasis Rev. 2005 Jun;24(2):273-85. doi: 10.1007/s10555-005-1577-9. Cancer Metastasis Rev. 2005. PMID: 15986137 Review.
• Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
  Das R, Philip S, Mahabeleshwar GH, Bulbule A, Kundu GC. Das R, et al. IUBMB Life. 2005 Jun;57(6):441-7. doi: 10.1080/15216540500159424. IUBMB Life. 2005. PMID: 16012053 Review.

Cited by

• miR-564 acts as a dual inhibitor of PI3K and MAPK signaling networks and inhibits proliferation and invasion in breast cancer.
  Mutlu M, Saatci Ö, Ansari SA, Yurdusev E, Shehwana H, Konu Ö, Raza U, Şahin Ö. Mutlu M, et al. Sci Rep. 2016 Sep 7;6:32541. doi: 10.1038/srep32541. Sci Rep. 2016. PMID: 27600857 Free PMC article.
• MDM2 promotes invasion and metastasis in invasive ductal breast carcinoma by inducing matrix metalloproteinase-9.
  Chen X, Qiu J, Yang D, Lu J, Yan C, Zha X, Yin Y. Chen X, et al. PLoS One. 2013 Nov 13;8(11):e78794. doi: 10.1371/journal.pone.0078794. eCollection 2013. PLoS One. 2013. PMID: 24236052 Free PMC article.
• Transcription Factor Profiling to Predict Recurrence-Free Survival in Breast Cancer: Development and Validation of a Nomogram to Optimize Clinical Management.
  Chen H, Ma X, Yang M, Wang M, Li L, Huang T. Chen H, et al. Front Genet. 2020 Apr 24;11:333. doi: 10.3389/fgene.2020.00333. eCollection 2020. Front Genet. 2020. PMID: 32391054 Free PMC article.
• Cancer development, progression, and therapy: an epigenetic overview.
  Sarkar S, Horn G, Moulton K, Oza A, Byler S, Kokolus S, Longacre M. Sarkar S, et al. Int J Mol Sci. 2013 Oct 21;14(10):21087-113. doi: 10.3390/ijms141021087. Int J Mol Sci. 2013. PMID: 24152442 Free PMC article. Review.
• Epithelial mesenchymal transition: a new insight into the detection of circulating tumor cells.
  Barrière G, Tartary M, Rigaud M. Barrière G, et al. ISRN Oncol. 2012;2012:382010. doi: 10.5402/2012/382010. Epub 2012 Apr 11. ISRN Oncol. 2012. PMID: 22577580 Free PMC article.

References

1. 1. Arboleda MJ, Lyons JF, Kabbinavar FF, Bray MR, Snow BE, Ayala R, Danino M, Karlan BY, Slamon DJ. Overexpression of AKT2/protein kinase B beta leads to up-regulation of β1 integrins, increased invasion, and metastasis of human breast and ovarian cancer cells. Cancer Res. 2003;63:196–206. - PubMed
2. 1. Cheng JQ, Godwin AK, Bellacosa A, Taguchi T, Franke TF, Hamilton TC, Tsichlis PN, Testa JR. AKT2, a putative oncogene encoding a member of a subfamily of protein-serine/threonine kinases, is amplified in human ovarian carcinomas. Proc Natl Acad Sci USA. 1992;89:9267–9271. - PMC - PubMed
3. 1. Franke TF, Yang SI, Chan TO, Datta K, Kazlauskas A, Morrison DK, Kaplan DR, Tsichlis PN. The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase. Cell. 1995;81:727–736. - PubMed
4. 1. Scheid MP, Woodgett JR. Unravelling the activation mechanisms of protein kinase B/Akt. FEBS Lett. 2003;546:108–112. doi: 10.1016/S0014-5793(03)00562-3. - DOI - PubMed
5. 1. Nicholson KM, Anderson NG. The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal. 2002;14:381–395. doi: 10.1016/S0898-6568(01)00271-6. - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • BioMed Central
  • Europe PubMed Central
  • PubMed Central

• Medical

  • MedlinePlus Health Information

• Miscellaneous

  • NCI CPTAC Assay Portal